Literature DB >> 23129754

IL-7 abrogates suppressive activity of human CD4+CD25+FOXP3+ regulatory T cells and allows expansion of alloreactive and autoreactive T cells.

Anne-Kristin Heninger1, Anke Theil, Carmen Wilhelm, Cathleen Petzold, Nicole Huebel, Karsten Kretschmer, Ezio Bonifacio, Paolo Monti.   

Abstract

CD4(+)CD25(+)FOXP3(+) regulatory T cells (Tregs) control the activation and expansion of alloreactive and autoreactive T cell clones. Because uncontrolled activation and expansion of autoreactive T cells occur in an IL-7-rich environment, we explored the possibility that IL-7 may affect the function of Treg. We show that the functional high-affinity IL-7R is expressed on both naive and memory Tregs, and exposure to IL-7 results in STAT-5 phosphorylation. Naive, but not memory, Tregs proliferated greatly and acquired a memory phenotype in the setting of a suppression assay when IL-7 was present. Importantly, the presence of IL-7 abrogated the capacity of Tregs to suppress proliferation of conventional T cells in response to TCR activators, including alloantigens and autoantigens. Removal of IL-7 restored the suppressive function of Tregs. Preblocking of the IL-7R on the Tregs also restored suppressor function, indicating that IL-7 directly affected Treg function. Thus, prolonged periods of homeostatic expansion can temporarily release natural regulatory brakes on T cells, thereby providing an additional mechanism for activating and expanding alloreactive and autoreactive T cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23129754     DOI: 10.4049/jimmunol.1201286

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  Immune mediators of chronic pelvic pain syndrome.

Authors:  Stephen F Murphy; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Nat Rev Urol       Date:  2014-04-01       Impact factor: 14.432

2.  Comparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinoma.

Authors:  Hui Liu; Jianyu Li; Fengmei Wang; Yingtang Gao; Ying Luo; Peng Wang; Chenglong Li; Zhengyan Zhu
Journal:  Tumour Biol       Date:  2014-11-24

Review 3.  IL7RA genetic variants differentially affect IL-7Rα expression and alternative splicing: a role in autoimmune and infectious diseases?

Authors:  Christian Lundtoft; Julia Seyfarth; Marc Jacobsen
Journal:  Genes Immun       Date:  2020-01-13       Impact factor: 2.676

4.  IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor.

Authors:  Keishi Adachi; Yosuke Kano; Tomohiko Nagai; Namiko Okuyama; Yukimi Sakoda; Koji Tamada
Journal:  Nat Biotechnol       Date:  2018-03-05       Impact factor: 54.908

5.  Dominant TNFα and impaired IL-2 cytokine profiles of CD4+ T cells from children with type-1 diabetes.

Authors:  Julia Seyfarth; Katharina Förtsch; Heinz Ahlert; Hans-Juergen Laws; Beate Karges; Rene Deenen; Karl Köhrer; Ertan Mayatepek; Thomas Meissner; Marc Jacobsen
Journal:  Immunol Cell Biol       Date:  2017-04-05       Impact factor: 5.126

Review 6.  Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

Authors:  Daniel F Sheehy; Sean P Quinnell; Arturo J Vegas
Journal:  Biochemistry       Date:  2019-01-17       Impact factor: 3.162

Review 7.  Interleukin-7 and type 1 diabetes.

Authors:  Paolo Monti; Ezio Bonifacio
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

8.  A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model.

Authors:  Shicheng Yang; Gary E Archer; Catherine E Flores; Duane A Mitchell; John H Sampson
Journal:  Cancer Immunol Immunother       Date:  2013-08-27       Impact factor: 6.968

Review 9.  Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis.

Authors:  Heinz Wiendl; Catharina C Gross
Journal:  Nat Rev Neurol       Date:  2013-06-04       Impact factor: 42.937

10.  HIV-1 infection impairs regulatory T-cell suppressive capacity on a per-cell basis.

Authors:  Mathieu Angin; Siddhartha Sharma; Melanie King; Thomas T Murooka; Musie Ghebremichael; Thorsten R Mempel; Bruce D Walker; Manoj K Bhasin; Marylyn M Addo
Journal:  J Infect Dis       Date:  2014-03-23       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.